Becker's Spine Review

33 DEVICES & IMPLANTS • In May, the company revealed its Magec X for early onset scoliosis treatment. • During the first quarter conference call, NuVasive CEO Gregory Lucier dis- cussed the company's focus on outpatient spine and biologics, and why the company will not dive into the robotics business. • NuVasive is also collaborating with the Scoliosis Research Society, Internation- al Spine Study Group Foundation to complete the Adult Symptomatic Lum- bar Scoliosis 2 study. Stryker (Kalamazoo, Mich.) Stryker reported net sales increased 9.7 per- cent year-over-year, generating $3.2 billion in the first quater of 2018. e company's orthopedic segment jumped 7.1 percent in sales year-over-year. Stryker's neurotechnolo- gy and spine segment experienced the largest growth; net sales totaled $600 million for the quarter. Stryker's 2017 full-year net sales in- creased 9.9 percent to $12.4 billion. Neuro- technology and spine sales grew 8.2 percent to $2.1 billion. in the first quarter of 2018. Here's what the company has been up to in 2018: • In February, Stryker achieved 95 per- cent ownership of Vexim. Stryker also completed its $662 million acquisition of Entellus Medical in March. • In March, the company reported 311 surgeons had implanted its Tritanium C Anterior Cervical Cage since launch in October 2017. • Also in March, the FDA granted clear- ance for its Tritanium TL Curved Poste- rior Lumbar Cage. • In May, Stryker acquired Hygia Health Services, a developer of single-use de- vices, to help hospitals reduce costs. • Stryker's Group President of Global Quality and Business Operation Lon- ny Carpenter plans to retire March 31, 2019. Mr. Carpenter ends a 30-year ca- reer at Stryker. Zimmer Biomet (Warsaw, Ind.) Zimmer Biomet saw $2 billion-plus in net sales in the first quarter of 2018. The com- pany's spine segment sales reached about $183 million for the quarter, a decrease of 1.7 percent year-over-year. The compa- ny reported $7.82 billion in full-year 2017 sales. Here's what the company has been up to in 2018: • Zimmer Biomet CEO Bryan Han- son commented on the company's sales decline in the first quarter conference call, "Broadly speaking, I want to em- phasize that although we are currently seeing negative year-over-year sales growth, we do expect to accelerate our topline performance to market growth rates or better over the next 18 to 24 months." • In March, Zimmer Biomet signed an agreement with the U.S. Department of Energy to join its Better Buildings, Bet- ter Plants program; the company com- mitted to reducing its energy intensity by 25 percent over the next 10 years. • In April, the company partnered with Warsaw (Ind.) Community Schools to continue expanding STEM initiatives. • Zimmer Biomet is also partnering with the Scoliosis Research Society, Interna- tional Spine Study Group Foundation to complete the Adult Symptomatic Lum- bar Scoliosis I2 study. n Medtronic launches 3D printing platform for titanium spinal implants: 4 insights By Shayna Korol M edtronic launched TiONIC Technology, a tita- nium 3D printed platform for spinal implants, at the American Association of Neurological Surgeons Annual Meeting in New Orleans May 1. Here are four things to know: 1. TiONIC Technology creates enhanced surface textures through a differentiated laser method. 2. The recently launched ARTiC-L Spinal System is the first Medtronic implant to be manufactured with the TiONIC Technology 3D printing technique. 3. The titanium implant is designed for use in transforam- inal lumbar interbody fusion procedures. The ARTiC-L's 3-D printed honeycomb design acts as an osteoconductive scaf- fold for bony growth into the implant, and it is intended to provide improved mechanical load distribution across the implant. 4. ARTiC-L only requires one instrument for implant insertion and positioning. The system is designed to facilitate sagittal alignment of the spine by providing several lordotic angles up to 20 degrees. n NuVasive Precise Stryde System used in 1st patient: 5 highlights By Mackenzie Garrity D ror Paley, MD, became the first physician to use NuVasive's Precise Stryde System for stature lengthening. Here are five highlights: 1. NuVasive's Precise Stryde System is part of the NuVa- sive Specialized Orthopedics product portfolio. It is an internal system for stature lengthening and limb recon- struction. 2. Precise Stryde is the third-generation limb lengthen- ing system in the NSO line. It includes an implantable intramedullary nail, locking screws, reusable instruments and a hand-help external remote controller. 3. NuVasive received FDA clearance for the lengthening system in April for use in the tibia and femur. 4. It is estimated the Precise Stryde System can increase a patient's height by more than three inches. 5. Dr. Paley founded the Paley Orthopedic & Spine In- stitute in West Palm Beach, Fla. He is an expert in limb lengthening and deformity correction. n

• Cover